- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about DNA
Recent news which mentions DNA
From Motley Fool
28 Biggest Movers From Yesterday
April 14, 2022
From Benzinga
Why Is Ginkgo Bioworks (DNA) Stock Up Today?
April 13, 2022
From InvestorPlace
From Benzinga
From InvestorPlace
3 Things About Ginkgo Bioworks That Smart Investors Know
April 01, 2022
Tickers
DNA
From Motley Fool
53 Biggest Movers From Yesterday
March 30, 2022
From Benzinga
36 Stocks Moving In Tuesday's Mid-Day Session
March 29, 2022
From Benzinga
Tickers
DNA
From InvestorPlace
8 Materials Stocks Moving In Tuesday's Pre-Market Session
March 29, 2022
From Benzinga
Earnings Scheduled For March 28, 2022
March 28, 2022
From Benzinga
3 No-Brainer Stocks to Buy Right Now for Less Than $6
March 26, 2022
From Motley Fool
From MarketWatch
Is Ginkgo Bioworks a Warren Buffett Stock?
March 17, 2022
From Motley Fool
From Benzinga
3 Unstoppable Growth Stocks to Buy in 2022 and Beyond
March 10, 2022
From Motley Fool
From Benzinga
2 Growth Stocks That Wall Street Thinks Can Double in Value
February 24, 2022
From Motley Fool
Is This SPAC a Buy After Falling More Than 50%?
February 18, 2022
From Motley Fool
7 Stocks to Buy After Sentiment Slipped to Lows
February 17, 2022
Tags
MTN
NASDAQ:CRWD,NASDAQ:LCID,NYSE:TWTR,NASDAQ:FRSH,NYSE:DNA,NYSE:MTN,NASDAQ:PLTK,NASDAQ:DWAC
Market News
From InvestorPlace
Did Going Public Give This Company Momentum? Stran & Company Closes First Acquisition; Adds Over $7 Million in Annualized Revenue
February 03, 2022
From Benzinga
Why BofA Sees 'Better Entry Point' In Ginkgo Bioworks Stock
January 28, 2022
Tickers
DNA
From Benzinga
Ginkgo Bioworks Announces Acquisition Of Massachusetts COVID-19 Testing Provider Project Beacon COVID-19 LLC; Terms Not Disclosed
January 19, 2022
Tickers
DNA
From Benzinga
If You Invested $1,000 When Illumina Acquired Solexa, Here's How Much You'd Have Now
January 12, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.